Related Experiment Videos
Prevention of gram-positive sepsis in neonates weighing less than 1500 grams
M A Kacica1, M J Horgan, L Ochoa
1Department of Pediatrics, Albany Medical College, NY 12208.
Insights
Continuous low-dose vancomycin infusion effectively prevented gram-positive bacteremia in very low birth weight neonates. This intervention significantly reduced infection rates, offering a promising strategy for vulnerable infants.
Area of Science:
- Neonatal Medicine
- Infectious Disease Prevention
- Pharmacology
Background:
- Nosocomial gram-positive bacteremia poses a significant risk to neonates weighing less than 1500 grams.
- Preventing bloodstream infections is crucial for improving outcomes in this vulnerable population.
Purpose of the Study:
- To evaluate the efficacy of continuous low-dose vancomycin infusion in preventing nosocomial gram-positive bacteremia in very low birth weight neonates.
- To assess the safety and impact of vancomycin administration via total parenteral nutrition.
Main Methods:
- A prospective, randomized study involving neonates weighing < 1500 gm.
- Intervention group received continuous vancomycin infusion (25 µg/ml) in total parenteral nutrition; control group received standard care.
- Clinical parameters including birth weight, gestational age, and severity of illness were similar between groups.
Main Results:
- A significant reduction in gram-positive bacteremia was observed in the vancomycin group (1/71) compared to the control group (24/70) (p < 0.001).
- No vancomycin-resistant organisms were detected during the 2-year study.
- Mean serum vancomycin concentration was 2.4 µg/ml, with administration for a mean of 11 days.
Conclusions:
- Continuous low-dose vancomycin infusion added to alimentation fluids virtually eliminated gram-positive bacteremia in very low birth weight infants.
- While effective, widespread use is cautioned pending further data on vancomycin resistance emergence.
Abstract:
A prospective, randomized study to evaluate the effectiveness of a continuous low-dose vancomycin infusion to prevent nosocomial gram-positive bacteremia was initiated within the first 2 weeks of life in neonates weighing < 1500 gm. Seventy-one infants received constant infusion of vancomycin (25 micrograms/ml) mixed with their total parenteral nutrition solution; 70 infants served as control subjects. The groups were clinically similar in birth weight, estimated gestational age, and severity of illness. Administration of vancomycin was begun at a mean age of 5.4 +/- 2.9 days. Infants had mean serum vancomycin concentrations of 2.4 micrograms/ml, and received vancomycin for a mean of 11 +/- 7 days. No vancomycin-resistant organisms were detected in surveillance cultures during the 2-year study period. Twenty-four of seventy control infants, in comparison with 1 of 71 infants receiving vancomycin, had gram-positive bacteremia (p < 0.001). The addition of a low dose of vancomycin to alimentation fluids virtually eliminated the incidence of gram-positive bacteremia in an at-risk population of very low birth weight infants. However, the widespread use of vancomycin in total parenteral nutrition solution is not recommended until better data on the emergence of vancomycin-resistant organisms are available.